CVA Family Office’s Organon & Co OGN Stock Holding History

CVA Family Office’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01K	Buy	169 +119	+238%	+$895	﹤0.01%	1648
2025 Q4	$359	Hold	50	–	–	﹤0.01%	1263
2025 Q3	$533	Hold	50	–	–	﹤0.01%	1234
2025 Q2	$482	Hold	50	–	–	﹤0.01%	1243
2025 Q1	$740	Buy	50 +1	+2%	+$15	﹤0.01%	1158
2024 Q4	$729	Sell	49 -13	-21%	-$212	﹤0.01%	1147
2024 Q3	$1.19K	Buy	62 +1	+2%	+$21	﹤0.01%	1053
2024 Q2	$1.27K	Buy	61 +1	+2%	+$20	﹤0.01%	1031
2024 Q1	$1.14K	Buy	60 +1	+2%	+$17	﹤0.01%	991
2023 Q4	$857	Buy	+59	New	+$803	﹤0.01%	998
2023 Q3	–	Sell	-1,539	Closed	-$32K	–	718
2023 Q2	$32K	Buy	1,539 +1,020	+197%	+$22.2K	0.01%	533
2023 Q1	$12.2K	Buy	519 +175	+51%	+$4.7K	﹤0.01%	663
2022 Q4	$9.6K	Sell	344 -138	-29%	-$3.53K	﹤0.01%	665
2022 Q3	$11K	Buy	482 +1	+0.2%	+$30	﹤0.01%	615
2022 Q2	$16K	Hold	481	–	–	﹤0.01%	577
2022 Q1	$17K	Hold	481	–	–	﹤0.01%	596
2021 Q4	$15K	Buy	+481	New	+$15.7K	﹤0.01%	574
2021 Q3	–	Sell	-791	Closed	-$24K	–	716
2021 Q2	$24K	Buy	+791	New	+$26K	0.01%	494

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

CVA Family Office's OGN Position: Q1 2026 in Review

CVA Family Office increased its Organon & Co (OGN) stake by 238% in Q1 2026, buying an estimated $895 and bringing the position to 169 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

CVA Family Office first reported a position in OGN in Q2 2021 and has held it in 18 quarters since. The position peaked at $32K in Q2 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

CVA Family Office held 169 shares of Organon & Co worth $1.01K as of Q1 2026.
CVA Family Office bought 119 Organon & Co shares in Q1 2026, an estimated $895.
Organon & Co made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1648 holding.
CVA Family Office first reported a position in Organon & Co in Q2 2021 and has held it in 18 quarters since.
CVA Family Office's Organon & Co position peaked at $32K in Q2 2023.
603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.